The emerging approach of the medication represents a significant breakthrough in the management of diabetes mellitus type 2. Unlike existing therapies, tirzepatide affects two pathways – GLP-1 and GIP – resulting https://tirzepatidepeptide820550.ka-blogs.com/95552565/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment